Krogerus advises Swedbank on Nightingale Health's IPO
Krogerus advises Swedbank as Sole Global Coordinator and Bookrunner in the initial public offering of Nightingale Health on Nasdaq First North Growth Market Finland.
Nightingale Health's IPO is by far the largest initial public offering on Nasdaq First North Growth Market in Finland to date, with gross proceeds of approximately EUR 110 million and a total value of approximately EUR 126 million if the over-allotment option is exercised in full. The full exercise of the over-allotment option also implies a market capitalisation of approximately EUR 425 million immediately prior to the commencement of trading.
The Krogerus team was led by Partner Tom Fagernäs and included Partner Elect Paul Raade and Associates Olli Silvennoinen and Samuli Torpisto.